Cassipa (buprenorphine and naloxone) sublingual film is a partial‐opioid agonist and opioid antagonist combination indicated for the maintenance treatment of opioid dependence.

Cassipa is the first buprenorphine and naloxone sublingual film product to be approved in the new higher dosage strength (buprenorphine 16 mg / naloxone 4 mg). Suboxone sublingual film and its generic equivalents are available in lower strengths: 2 mg/0.5mg, 4 mg/1 mg, 8 mg/2mg and 12mg/3mg.

About

Terms & Privacy

Subscribe to receive email notifications whenever new articles are published.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 May 2019), Cerner Multum™ (updated 2 May 2019), Wolters Kluwer™ (updated 1 May 2019) and others.